lisuride has been researched along with oxidopamine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunow, M; Löschmann, PA; Wachtel, H | 2 |
| Fink, H; Morgenstern, R; Ott, T | 1 |
| Fletcher, GH; Starr, MS | 2 |
| Guilarte, TR; May, CH; Vogel, S; Wagner, HN | 1 |
| Brotchie, JM; Crossman, AR; Henry, B | 2 |
| Battaglia, G; Biagioni, F; Busceti, CL; Fornai, F; Giorgi, FS; Molinaro, G; Ruggieri, S | 1 |
| Chen, JF; Herm, L; Kalda, A; Rinken, A; Zharkovsky, A | 1 |
| Cho, J; Kim, G; Kim, M; Lee, S; Won, C | 1 |
11 other study(ies) available for lisuride and oxidopamine
| Article | Year |
|---|---|
NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Apomorphine; Dopamine Agents; Drug Synergism; Ibotenic Acid; Lisuride; Male; Neurons; Oxidopamine; Parkinson Disease, Secondary; Piperazines; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Substantia Nigra; Sympathectomy, Chemical | 1992 |
Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Drug Synergism; Lisuride; Male; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Quinoxalines; Rats; Rats, Wistar; Stereotaxic Techniques; Substantia Nigra | 1992 |
2-Bromolisuride, an ergot derivative, with dopamine antagonistic and serotonin agonistic properties.
Topics: Animals; Apomorphine; Cyproheptadine; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Hydroxydopamines; Limbic System; Lisuride; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin; Stereotyped Behavior; Sympathectomy, Chemical | 1991 |
Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Brain Mapping; Corpus Striatum; Female; Hydroxydopamines; Lisuride; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1987 |
Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Brain; Hydroxydopamines; Lisuride; Metoclopramide; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior | 1987 |
Intrastriatal infusion of lisuride--a potential treatment for Parkinson's disease? Behavioral and autoradiographic studies in 6-OHDA lesioned rats.
Topics: Animals; Autoradiography; Corpus Striatum; Infusions, Parenteral; Lisuride; Male; Motor Activity; Oxidopamine; Parkinson Disease; Radioligand Assay; Rats; Rotation | 1994 |
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Clonidine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Levodopa; Lisuride; Locomotion; Male; Mazindol; Methoxydimethyltryptamines; Oxidopamine; Parkinson Disease, Secondary; Prosencephalon; Rats; Rats, Sprague-Dawley; Sympatholytics; Tritium; Yohimbine | 1998 |
Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Topics: Animals; Autoradiography; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine Uptake Inhibitors; Enkephalins; In Situ Hybridization; Levodopa; Lisuride; Male; Mazindol; Medial Forebrain Bundle; Neostriatum; Oligonucleotide Probes; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; Radioligand Assay; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1999 |
Dopamine stimulation via infusion in the lateral ventricle.
Topics: Animals; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Infusion Pumps; Injections, Intraventricular; Lateral Ventricles; Lisuride; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Dopamine | 2006 |
Co-administration of the partial dopamine D2 agonist terguride with L-dopa attenuates L-dopa-induced locomotor sensitization in hemiparkinsonian mice.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Benzazepines; Caffeine; Corpus Striatum; Dopamine Agonists; Drug Therapy, Combination; Guanosine 5'-O-(3-Thiotriphosphate); Levodopa; Lisuride; Male; Mice; Mice, Inbred C57BL; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Random Allocation; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulfur Radioisotopes | 2009 |
Dopamine D3 receptor-modulated neuroprotective effects of lisuride.
Topics: Animals; ATPases Associated with Diverse Cellular Activities; Biphenyl Compounds; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Indoles; Lisuride; Male; Metalloendopeptidases; Mice; Mitochondria; Neuroprotective Agents; Oxidopamine; Piperazines; Piperidines; Primary Cell Culture; Receptors, Dopamine D3; Tyrosine 3-Monooxygenase | 2017 |